Projects per year
Personal profile
Education
- 1998-2003 Ph.D., The Institute of Basic Medical Sciences, National Cheng Kung University
- 1996-1998 M.S., Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University
- 1989-1994 B.S., Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University
Experience
- 2018.02- Professor, International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University
- 2018.02- Professor, International Ph.D. Program for Cell Therapy and Regeneration Medicine, Taipei Medical University
- 2016.11-2017.10 Professor, International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University
- 2013.02- Professor, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2011.10-2012.10 Director, Laboratory Animal Center, Taipei Medical University
- 2010.02-2013.01 Associate Professor, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2007.02-2010.01 Assistant Professor, School of Medicine, Taipei Medical University
- 2006.09-2007.02 Clinical researcher Department of Surgery, Taipei Medical University Hospital, Tapei, Taiwan
- 2004.11-2006.08 Postdoctoral Fellow, University of Rochester, NY, USA
- 2003.11-2004-10 Postdoctoral Fellow, National Cheng-Kung University, Tainan, Taiwan
Research Interests
- Molecular Biology
- Protein Chemistry
- Emzymology
- Hematology
- Cancer Biology
- Biochemistry
Awards
- 2016 Faculty Award of Taipei Medical University
Fingerprint
Dive into the research topics where Yu-Jia Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 12 Finished
-
探討 CWH43 大腸直腸癌發展的角色及其調控機制
8/1/20 → 7/1/21
Project: A - Government Institution › b - National Science and Technology Council
-
To Study the Role of Slc35b4 in the Progression of Colorectal Cancer and Molecular Mechanism
8/1/19 → 7/31/20
Project: A - Government Institution › b - National Science and Technology Council
-
To Study the Role of Slc35b4 in the Progression of Colorectal Cancer and Molecular Mechanism
8/1/18 → 7/1/19
Project: A - Government Institution › b - National Science and Technology Council
-
To Study the Role of Slc35b4 in the Progression of Colorectal Cancer and Molecular Mechanism
8/1/17 → 7/31/18
Project: A - Government Institution › b - National Science and Technology Council
-
Studied the Roles of Grp94 in the Progression and Metastasis of Esophageal Squamous Carcinoma, Mechanism Dissection, and Drug Development
8/1/16 → 7/31/17
Project: A - Government Institution › b - National Science and Technology Council
-
In silico analysis to identify miR-1271-5p/PLCB4 (phospholipase C Beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancer
Lee, C-C., Lee, A-W., Wei, P-L., Liu, Y-S., Chang, Y-J. & Huang, C-Y., 2023, In: Scientific Reports. 13, 1Research output: Contribution to journal › Article › peer-review
-
Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53
Wang, W. L., Batzorig, U., Hung, C. S., Wei, P. L., Huang, C. Y. & Chang, Y. J., 2022, In: BioMed Research International. 2022, 1322788.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
A Novel IGLC2 Gene Linked With Prognosis of Triple-Negative Breast Cancer
Chang, Y. T., Tsai, W. C., Lin, W. Z., Wu, C. C., Yu, J. C., Tseng, V. S., Liao, G. S., Hu, J. M., Hsu, H. M., Chang, Y. J., Lin, M. C., Chu, C. M. & Yang, C. Y., Jan 27 2022, In: Frontiers in Oncology. 11, 759952.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
Human α-defensin 6 (HD6) suppresses CRC proliferation and metastasis through abolished EGF/EGFR signaling pathway
Wei, P. L., Lin, J. C., Hung, C. S., Makondi, P. T., Batzorig, U., Chang, T. C., Huang, C. Y. & Chang, Y. J., 2022, In: International Journal of Medical Sciences. 19, 1, p. 34-46 13 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
The Natural Compound Dehydrocrenatidine Attenuates Nicotine-Induced Stemness and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma by Regulating a7nAChR-Jak2 Signaling Pathways
Li, C. L., Wang, C. C., Pai, H. T., Tu, S. L., Hou, P. Y., Huang, C. Y., Huang, M. T. & Chang, Y. J., 2022, In: Disease Markers. 2022, 8316335.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus)
Datasets
-
MOESM1 of Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression
Huang, S. (Creator), Chiou, C. (Contributor), Lee, C. (Contributor), Chang, T. (Creator), Lu, T. (Contributor), Yu, C. (Contributor), Bao, B. (Contributor), Chen, L. (Contributor), Chang, Y. (Creator), Huang, C. (Creator), Lin, I. (Creator) & Lin, V. C. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.7961648.v1, https://doi.org/10.6084%2Fm9.figshare.7961648.v1
Dataset
-
Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression
Yu, C. (Contributor), Chen, L. (Contributor), Chiou, C. (Contributor), Chang, Y. (Creator), Lin, V. C. (Creator), Huang, C. (Creator), Lin, I. (Creator), Chang, T. (Creator), Lu, T. (Contributor), Lee, C. (Contributor), Huang, S. (Creator) & Bao, B. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.c.4462265.v1, https://doi.org/10.6084%2Fm9.figshare.c.4462265.v1
Dataset